Johnson & Johnson Secures FDA Approval for ICOTYDE™ – A Breakthrough Oral Therapy for Plaque Psoriasis
Johnson & Johnson has secured approval from the U.S. Food and Drug Administration for ICOTYDE™, a once-daily oral therapy designed […]
News
Eli Lilly Enters In Vivo CAR-T Space with Up to $2.4 Billion Acquisition of Orna Therapeutics
Eli Lilly has taken a decisive step into the rapidly evolving field of in vivo CAR-T therapy through the acquisition
Estrella Immunopharma Reports 100% Complete Response in Second Dose Cohort of EB103 Trial for Advanced B-Cell Non-Hodgkin’s Lymphoma
According to Towards Healthcare Study, Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical innovator developing CD19 and CD22-targeted ARTEMIS® T-cell therapies for
Thermo Fisher’s innovative carbon calculator to promote clinical trial sustainability
Thermo Fisher Scientific’s PPD™ clinical research business has unveiled an innovative carbon calculator designed to address the environmental impact of
FDA Approves Novo Nordisk’s Rybelsus as First Oral GLP-1 for Cardiovascular Risk Reduction
Bags FDA Approval for a Landmark Advancement in Cardiovascular and Diabetes Care Novo Nordisk has received approval from the U.S.
Mabwell’s CDH17-Targeting Cancer Drug 7MW4911 Receives IND Approvals from NMPA and FDA
Chinese biopharmaceutical innovator Mabwell has announced a major milestone in its oncology pipeline: its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,
Demetra Launches Global Spine Division Following Acquisition of OrthoFundamentals LLC
Global medical technology leader Demetra has announced the launch of its new spine-focused division, Demetra Spine, following its strategic acquisition
New Disease Mechanism Suspected in Ovarian Cancer Remission Patients, Landmark Study Reveals
A groundbreaking multi-institutional study has uncovered a hidden mechanism potentially responsible for the high recurrence rate in ovarian cancer patients,
Glioblastoma Funding Sees Surge as Nonprofits Drive Renewed Pharma Interest
In a promising turn for brain cancer research, funding for glioblastoma (GBM) has seen a significant uptick, spurred by nonprofit
Lotte Biologics Accelerates Global CDMO Expansion Across North America and Asia
Seoul, South Korea Lotte Biologics is making significant strides in expanding its global presence in the Contract Development and Manufacturing